About
PeptiCov is focused on discovering and developing an effective treatment for SARS-CoV-2. PeptiCov is a spin-off company of PeptiCom, a biotechnology company that uses artificial intelligence to streamline peptide drug discovery. PeptiCom's AI technology streamlines and significantly accelerates the ability to discover advanced peptide-based drug candidates by searching an enormous set of possible solutions, vastly reducing the risk of failure during development. It covers more possible molecular options, while simultaneously filtering out the most suitable candidates with properties such as solubility and permeability. This software analyzed several protein targets related to the coronavirus SARS-CoV-2 and designed a number of potential peptide drug candidates that were lab validated. PeptiCov is responsible for further development of these peptides and seeking partnerships with pharmaceutical companies.
Q&A
- What is PeptiCov's primary focus?
- PeptiCov is focused on discovering and developing an effective treatment for SARS-CoV-2.
- When was PeptiCov founded?
- PeptiCov was founded in January 2021.
- What is PeptiCov's current funding stage?
- PeptiCov is currently in the Pre-Funding stage.
- What is PeptiCov's relationship with PeptiCom?
- PeptiCov is a spin-off company of PeptiCom, a biotechnology company that uses artificial intelligence to streamline peptide drug discovery.
- What technology does PeptiCom utilize to develop drug candidates?
- PeptiCom's AI technology streamlines and accelerates the discovery of advanced peptide-based drug candidates by searching an enormous set of possible solutions and filtering out suitable candidates with properties like solubility and permeability.
- What is PeptiCov's role in the development of peptide drug candidates for SARS-CoV-2?
- PeptiCov is responsible for the further development of peptide drug candidates designed by PeptiCom's AI software for SARS-CoV-2 and for seeking partnerships with pharmaceutical companies.
- What is PeptiCov's primary sector classification?
- PeptiCov's primary sector is Health Tech & Life Sciences.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2021-1 |
|---|---|
| Employees (exact) | 6 |